Lantern Pharma Stock (NASDAQ: LTRN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 312.672K |
Day Range | - - - |
52 Wk Range | 2.380 - 11.990 |
Market Cap | $58.755M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 4.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.
Other companies in Lantern Pharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by HC Wainwright & Co. on Thursday, April 25, 2024. The analyst firm set a price target for 0.00 expecting LTRN to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $5.47 last updated April 25, 2024 at 6:35 PM EDT.
There are no upcoming dividends for Lantern Pharma.
Lantern Pharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.